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Heart Transplant Program Offers a New Lease on Life
The Surgeon Speaks

R

ussell Cerminara is not someone you
would readily identify as a patient in
a hospital, let alone someone on the
heart donor list. Casually dressed and
exceedingly well groomed, he lounges
comfortably in the waiting area outside
his room on the 5th floor of the Gibbon
Building – the Cardiac Unit – at Jefferson
University Hospital. If it weren’t for the IV
stand, and the small black Jansport
backpack that holds a device pumping
his heart, you’d never know he’d spent the
last decade battling a life-threatening
heart condition and been in the hospital
since April.
Every bit the image of a successful
television producer, Mr. Cerminara takes
calls on his blackberry when not doing
physical therapy or interacting with other
patients and family members. He’s
working to gain enough strength to go
home while he waits for a heart, which
could be a while given his O blood type.

Medicare Certified...the
highest quality indicator for a
transplant program, based on
the number of transplants
and clinical outcomes
On May 24, 2007, he received a Jarvik
2000® Heart Assist System. This is the
smallest and simplest of the axial flow
pumps in existence right now – the latest
technology in LVADs (Left Ventricle Assist
Devices), invented by Dr. Robert Jarvik.
Rather than taking over for the heart, the
Jarvik assists the patient’s weakened left
ventricle to pump blood throughout the
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“There are
several surgical
advantages to
the Jarvik Heart
for a patient like Russ Cerminara.
Like all LVADs, it is implanted with the
use of a heart and lung machine, but
it is less invasive and more gentle on
the heart itself. Patients rarely need
blood transfusions. And it can be
implanted through the left chest, which
is less risky for the patient because it
avoids creating dangerous scar tissue
in the middle chest.
Thanks to Jefferson surgeons, television producer Russ Cerminara now benefits from a
portable Jarvik 2000® Heart Assist System while he waits for a donor heart.

body. Jefferson was the first hospital in
Philadelphia to offer the groundbreaking
device, which has not yet been approved
by the FDA as standard treatment.
Mr. Cerminara is but one success story in
a young but impressive and growing
Heart Transplant Program at Jefferson –
which was Medicare Certified after only
a very short time. This is the highest
quality indicator for a transplant
program, based on the number of
transplants and clinical outcomes as
well as skill and professionalism of the
medical and surgical teams. For patients
with serious cardiac failure, this makes
Jefferson a financially viable option
for treatment.
The surgical team benefits from a
new surgical suite that contains
miniature equipment as well as
CLINICAL INTEGRATION
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state-of-the-art video monitoring devices.
James Diehl, MD, Director of the Division
of Cardiothoracic Surgery, says that this
makes more seamless procedures possible
that integrate endoscopy as well as
minimally invasive cardiac surgery
techniques. “What is more, he says,
“everyone in the operating room can see
the procedures with exceptional clarity.”
The quality of care speaks for itself.
“I’m going to make a television show
about this disease, treatment process, and
this device,” says Mr. Cerminara.
“Because the public in general is very
unaware of it, like I was.” His continued
recovery is sure to make this possible, and
will make for another of the compelling
and positive stories to which he continues
to be so devoted to telling.

CHANGING LIVES
THROUGH RESEARCH
More Veggies, Less
Breast Cancer - Page 3

“While Russ had battled heart failure
for many years, he had been successful
with various other treatments. It was
only when we saw that he was no
longer responsive to these therapies
that it became clear how limited his
options really were.
“He agreed it was time to begin
the evaluation process for a heart
transplant, and just a week before
he was to come in to start the tests,
he was rushed to the hospital and we
decided the LVAD was necessary. At
that point it was lifesaving. And now, as
Russ gains strength, we’re even more
optimistic about the potential outcomes
when a heart does become available.”
Scott C. Silvestry, MD
Director, Heart Transplantation and
Cardiac Mechanical Assist Program
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Clinical integration

Overview

CHARLES J. YEO, MD
Samuel D. Gross Professor and
Chair, Department of Surgery
It’s great to have a new academic year
underway, and also review the past
year’s accomplishments.
On the clinical side, there has been
fine growth of programs in Endovascular,
Minimally Invasive, Hepatopancreaticobiliary, Transplant, Cardiothoracic and
Trauma Surgery. We had a superb
Residency Review Committee site visit,
receiving five-year accreditation and a
commendation for educational initiatives.
Our complex case volume has grown
by approximately 40%. The SICU has
doubled in size, and we’ve expanded to
a satellite office at St. Agnes, adjacent
to Methodist Hospital.
On the research front, 41 research grants
were submitted and we currently have
15 funded research projects. The largest
grant came from the American College
of Surgeons and went to Dr. Arafat for her
work in pancreatic carcinogenesis.
A paper by Drs. Grabo, Kairys, and
DiMuzio on endovascular procedures,
presented at the American Surgical
Association in April, was recently
published in the Annals of Surgery.
Drs. Arafat and and Kennedy presented
at the Southern Surgical Association,
and Dr. Tarola presented at the American
Association of Plastic Surgery.
Furthermore, during Digestive Disease
Week, we had three oral presentations
and 10 poster presentations!

The new J. Wallace and Gail G. Davis
Professorship supports Dr. Thomas
Tulenko in his role as Director of the
Division of Surgical Research.
This has been a year of growth and
some change, but a year of overall
stability and productivity!

https://jdc.jefferson.edu/jss/vol2/iss1/10

Women who visit Jefferson-Honickman Breast Imaging enjoy personalized, state-of-the-art
care that is tailored to the unique issues and concerns of their particular age group.

Comprehensive Breast Program
Continues to Set the Trend

J

efferson continues to set the trend in
breast care with the opening of JeffersonHonickman Breast Imaging, located on
the 4th floor at 1100 Walnut Street, in January
2007. This is the first phase of a three phase
facility project that will provide our patients
with the most advanced expertise and
technology as well as personalized patient care
in a warm and comfortable environment.
The remaining phases of the Jefferson Breast
Care project include breast screening, an MRI
and a center for clinical, educational and
support services.
With the growth of a comprehensive breast
care program, Jefferson Surgeons continue to
be at the forefront of care. The surgical
practices of Drs. Gordon Schwartz, MD, MBA,
Anne Rosenberg, MD, and Kristin Brill, MD
are dedicated to breast surgery. Several
general surgeons also specialize in breast
surgery including Adam Berger, MD, Karen
Chojnacki, MD, Melvin Moses MD, Bernadette
Profeta, MD, and Gary Rosato, MD.
Dr. Rosenberg emphasizes
the comprehensive,
multidisciplinary services
available at Jefferson. “From
prevention and genetic
screening programs to early
detection as well as surgical Anne Rosenberg, MD
and non-surgical treatment options, we offer
the entire spectrum of the best of what
medical care has to offer today.”

Dr. Brill explains that we
are planning the new
Jefferson Breast Care Facility
to create an easy, stress-free
experience for patients. “The
program emphasizes
Kristin Brill, MD
communication between
patient and doctor, but also among surgeons,
radiologists, nurses, technologists, and other
healthcare providers,” she says. “The art of
what we do is to reassure women that
treatment can be customized to suit their
particular situation, lifestyle, and stage of life.”

Thanks to the skills of our plastic
surgeons, James Fox, MD, John H. Moore MD,
Stephen Copit, MD, and Gary Tuma, MD,
Jefferson leads national trends relating to
mastectomy and reconstruction, including
LAT Flap (Latissimus Dorsi Myocutaneous
Flap) reconstructions. “LAT Flaps” can be
much easier for women to live with than the
more traditional TRAM Flap reconstruction
that requires taking skin, muscle and fat
from the abdomen. Nationally, 30 to 35
percent of women have breast reconstruction
immediately following a mastectomy.
Jefferson’s rate for patients over the age
of 65 is even higher than that. “We show
no age bias,” says Dr. Brill, “and equally
encourage our older and younger patients
to take advantage of the excellent team of
plastic surgeons.”
Jefferson surgeons are
educators and leaders in the
field. Dr. Schwartz organizes a
highly respected biennial
international breast cancer
Consensus Conference. “We
do this to bring together the best Gordon Schwartz, MD, MBA
experts to discuss and debate a chosen topic and
ensure that the latest treatments are available to
patients worldwide,” explains Dr. Schwartz. The
Jefferson program also offers one of only 30
breast surgery fellowships across the country.
Visit www.jeffersonhospital.org/breast
for more information.

Please welcome

MEET OUR
SURGICAL INTERNS
Jefferson surgeons are
currently assisted by an
exceptional group of
categorical interns. These
doctors, who recently matched
with Jefferson, started on June
20, 2007 (shown left to right):
Allison Goldberg, MD, Albert
Einstein College of Medicine;
Adam Bodzin, MD, Boston University School
of Medicine; Joshua Marks, MD, Jefferson
Medical College; Jennie Baek, MD, Dartmouth
Medical School; Chandan Kundavaram, MD,
University of Arizona College of Medicine;
Vanessa Talbott, MD, George Washington
University School of Medicine.

We are also pleased to welcome back the
following Jefferson graduates as preliminary
interns: James Eiszner, MD and Roman
Politi, MD in General Surgery, Rohan
Chitale, MD in Neurosurgery and Daniel
Sackett, MD in Urology.

2

et al.: Download the PDF of the Entire Issue

Changing Lives Through Research

On the job
Lara Allan Goldstein
Lara Allan Goldstein is the Director of
Development for the Department of
Surgery. A Jefferson employee since
2003, she joined the department in
November 2006. Previously, she served
as the Director of Regional Giving for the
Jefferson Foundation.

Dr. Susan Lanza-Jacoby and her team lead groundbreaking studies on the links between
dietary elements and breast tumors.

More Veggies, Less Breast Cancer:
Unlocking One Secret to Prevention

W

e all know that eating a balanced diet
is good for us. Susan Lanza-Jacoby,
PhD, the Principal Investigator of the Cancer
Biology and Nutrition Laboratory in the
Department of Surgery, is taking this
conventional wisdom to new scientific
heights. She investigates molecular
abnormalities involved in the development
of breast cancer and aims to identify novel
strategies using food components for
prevention and treatment.
“We’re striving to show how dietary
supplements can slow down – or even stop –
the incidence of breast cancer, and also
improve the effectiveness of chemotherapy,”
Dr. Jacoby explains, “so that a woman can
take lower doses and also minimize the
side effects.”
Learning how to prevent or treat tumors
in the human breast requires working in her
lab with “transgenic” mice – those with
compromised immune systems that receive
implanted tumor cells. The mice are made
to overexpress a cancer-causing gene
(HER-2/neu), which inevitably results in
them developing mammary tumors. (This is
the laboratory equivalent of being genetically
predisposed to getting breast cancer.)

“Breast tumors that overexpress this
gene are aggressive,” says Dr. Jacoby. “They
account for between 20 and 25 percent of all
breast cancer in women, and do not respond
well to standard treatments, which results in
a poor prognosis for the patient.”
Her research suggests that a number
of dietary factors can have cancer-fighting
properties. Diindolylmethane (DIM) is a
component of certain vegetables, called
cruciferous (such as broccoli, cauliflower,

“We’re striving to show
how dietary supplements
can slow down – or even
stop – the incidence of
breast cancer”
cabbage, and Brussels sprouts), and members
of Dr. Jacoby’s lab have been observing that it
can decrease growth and even kill breast
cancer cells that result from overexpression
of the HER-2/neu gene.
She explains that mice fed our Western
diets took about 6 to 7 months to develop
breast tumors; whereas when they fed DIM
to the transgenic mice, it took over a year to
develop the tumors. “This is a significant

How do you define your role?
I meet with patients, families, and
friends of the Department and help to
find a match between what they want
to support and what the various
divisions and physicians need to make
their programs most successful,
whether it’s to expand programs,
pursue innovative research, or enhance
patient care.
What do you like about your position?
I enjoy working with individuals who
are so committed to Jefferson and want
to make a difference by giving back in
some way. It’s exciting to learn from the
patients and their families about the
great impact our Jefferson staff and
surgeons have had on their lives.
What’s a common misconception
about development?
I’m not sure people realize there are
many different ways to give, beyond an
outright cash gift. Appreciated stock,
real estate, and bequests are options,

delay,” she explains, “Consider the potential
for helping genetically predisposed adolescent
girls delay the onset of cancer until well into
their 50s or 60s.”
Dr. Jacoby is also investigating how
to develop combined therapies that will
prevent the development of breast tumors.
A multitargeted approach based on the
characteristics of the individual tumor has
provided more effective prevention and
treatment. “We measured the growth of
tumors in the mice, and when we used a
combination of the DIM supplement and
docetaxel, a chemotherapeutic another agent,
there was a significantly slower rate of tumor
growth.” She is also finding that a COX-2

as well as charitable gift annuities and
charitable trusts, which provide income
during a donor’s lifetime. Congress has
provided a temporary opportunity for
those 70 years of age to make a gift
directly from their IRA. These can be
attractive options for a donor who may
want to earn income, reduce capital
gains or estate taxes, or provide for
their heirs.
What is most satisfying about
the work you do?
It’s gratifying to see how pleased the
donors are when they see the
difference their generosity makes. It’s
great to help facilitate a process that
strengthens the Department in
achieving its mission.

inhibitor, used in combination with other
agents, can prevent the incidence of breast
tumors altogether.
In July Dr. Jacoby was awarded a research
grant from the Pennsylvania Department of
Health to continue her study of the role of the
ErbB and COX-2 signaling pathway in HER-2
breast cancer. Thanks to a grant from the
U.S. Department of Agriculture, she is
developing a teaching module about the role
of nutrition and cancer prevention, which
will mean her exciting findings to date will
have a direct path into patients’ lives.

For an appointment with a Jefferson Surgeon, call 1- 800 - JEFF - NOW
Published by Jefferson Digital Commons, 2007
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Those Who Give

Making a Difference
One Donation
at a Time

N

ot all gifts to Jefferson Surgery
come from a single
philanthropic individual.
Sylvia Berman, of Marblehead,
Massachusetts, is working tirelessly
to encourage others to make a
difference. Her daughter, Susan
Sillars, has been a patient of
Charles J. Yeo, MD, for many months
now, having been diagnosed with
pancreatic cancer. Tragically, Mrs.
Berman was already familiar with
the disease, which claimed the life
of her husband 14 years ago.
Last March, Dr. Yeo removed a
portion of Susan’s tumor so that
it could be studied as part of the
progressive research being done by
Jonathan Brody, PhD. His laboratory
has run countless assays on DNA
purified from her cancer cells in
search of identifying a genetic
defect. Such studies will lay the
ground work for tailored adjuvant
therapy for pancreatic
cancer patients.

In Gratitude for
Exceptional Care
During this difficult time, Mrs.
Berman has taken it upon herself
to raise funds to support Dr. Brody’s
research. So far she has raisedover
$32,000. “Because of this support,
we have been able to scrutinize Mrs.
Sillars’ tumor on the molecular
level. Our hope is that this
information will aid her family
and other pancreatic cancer
patients,” says Dr. Brody.
“The information that is out
there can be overwhelming, and
finding a surgical team who saw
things differently and could offer
us a new alternative has been
profoundly helpful,” says Mrs.
Berman. “It’s inspiring to see that
our network of family and friends
has offered so much kindness and
compassion as well as financial
support. It goes to show that
combining the generosity of many –
no matter how small the amounts –
can make a big difference.”
To make a contribution to the Susan Sillars
Fund for Pancreatic Cancer Research,
please visit
http://www.jefferson.edu/surgery/giving.cfm

nna Hotz, a Medford, NJ,
native, has made a gift to
the Jefferson Breast Care
Center in honor of her doctors Anne
Rosenberg, MD, and Stephen Copit,
MD. The commitment became a
family affair when her sons Jack,
Steven, and Chuck matched her
contribution with winnings from a
Cape May, NJ, fishing tournament
in April 2006.
Mrs. Hotz is grateful for the
excellent care she received and
the personal relationships she
developed with her physicians.
“Dr. Rosenberg, for all of her
accolades and reputation in the
field of breast cancer, is a very
regular, low-key person,” says
Mrs. Hotz. “And Dr. Copit is very
passionate with his patients and
about his practice. He treated me
like one of my own sons would
treat me.”
The Hotz family gift supports
the new Jefferson Breast Care
Center, where patients can receive
information, counseling, and other
support throughout their care in
one location.

A

News in Brief
Glenn Whitman, MD has joined the Department of Surgery’s
Divisions of Acute Care Surgery and Cardiothoracic Surgery. He
comes to Jefferson from Temple University where he served as
Associate Hospital Director of Perioperative Services and Director of
Transplantation. Dr. Whitman will head
Jefferson’s Surgical Cardiac Care Unit.
Pankaj Patel, MD (JMC Class of
1991), has joined the Division of Acute
Care Surgery. Dr. Patel is returning to
Jefferson from Penn State College of
Medicine. He specializes in Trauma
and Surgical Critical Care.
Pankaj Patel, MD
Vincent Armenti, MD, PhD (JMC Class of 1982), has returned
from Temple University to teach and continue his work as Principal
Investigator of the National Transplantation Pregnancy Registry which
he founded at Jefferson in 1991. He holds a primary appointment in
the Department of Pathology, Anatomy and Cell Biology.
Paul DiMuzio, MD has been named Director of the Division
of Vascular Surgery and the Measey Professor of Surgery.
Cataldo Doria, MD, PhD has been named Director of the
Division of Transplant Surgery.
Thomas Tulenko, PhD Director of the Division of Surgical Research,
received the Dean’s Citation for Outstanding Faculty Mentoring and
was also recently awarded Diplomate status with the Accreditation
Council for Clinical Lipidology.
Gerald Isenberg, MD has been named an Honorary Fellow of the
Puerto Rico Chapter of the American College of Surgeons.
Kate Vinod a first year JMC student, has been awarded a national
one-year Student Research Fellowship by the American Vascular
Association. Her project, “Differentiation of Amniotic Fluid Stem
Cells”, will proceed under the direction of Dr. Paul DiMuzio.

To make a gift to the Department of Surgery, please contact Lara Allan Goldstein at 215-955-8797 or Lara.AllanGoldstein@Jefferson.edu.
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